Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Norris

Showing results (351-360 of 375) with videos related to

Pageof 38
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2005
Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathwayTimothy C Cheung, Ian R Humphreys, Karen G Potter, et al.
Gut|July 25, 2015
LTβR signalling preferentially accelerates oncogenic AKT-initiated liver tumoursAnthony J Scarzello, Qun Jiang, Timothy Back, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 23, 2012
LCL124, a cationic analog of ceramide, selectively induces pancreatic cancer cell death by accumulating in mitochondriaThomas H Beckham, Ping Lu, Elizabeth E Jones, et al.
Cancer Gene Therapy|June 10, 2006
Combined therapeutic use of AdGFPFasL and small molecule inhibitors of ceramide metabolism in prostate and head and neck cancers: a status reportJ S Norris, A Bielawska, T Day, et al.
Elife|November 1, 2021
A novel, ataxic mouse model of ataxia telangiectasia caused by a clinically relevant nonsense mutationHarvey Perez, May F Abdallah, Jose I Chavira, et al.
The Journal of Experimental Medicine|March 16, 2021
ILC3s control splenic cDC homeostasis via lymphotoxin signalingMatthias Vanderkerken, Antonio P Baptista, Marco De Giovanni, et al.
Injury|August 26, 2022
Assessment of safety and effectiveness of non-neurosurgical management for minimal traumatic brain injury (TBI)Jeffrey W Chen, Aaron Yengo-Kahn, Silky Chotai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2020
Results of the ADAPT Phase 3 Study of Rocapuldencel-T in Combination with Sunitinib as First-Line Therapy in Patients with Metastatic Renal Cell CarcinomaRobert A Figlin, Nizar M Tannir, Robert G Uzzo, et al.
Frontiers in Bioscience : a Journal and Virtual Library|November 6, 2007
Acid ceramidase inhibition: a novel target for cancer therapyXiang Liu, Saeed Elojeimy, Lorianne S Turner, et al.
Expert Review of Gastroenterology & Hepatology|March 10, 2017
Effectiveness of interferon-free therapy for the treatment of HCV-patients with compensated cirrhosis treated through the Irish early access programE Gray, A O'Leary, C Bergin, et al.
Pageof 38

Showing results (351-360 of 375) with videos related to

Sort By:
Pageof 38
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2005
Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathwayTimothy C Cheung, Ian R Humphreys, Karen G Potter, et al.
Gut|July 25, 2015
LTβR signalling preferentially accelerates oncogenic AKT-initiated liver tumoursAnthony J Scarzello, Qun Jiang, Timothy Back, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 23, 2012
LCL124, a cationic analog of ceramide, selectively induces pancreatic cancer cell death by accumulating in mitochondriaThomas H Beckham, Ping Lu, Elizabeth E Jones, et al.
Cancer Gene Therapy|June 10, 2006
Combined therapeutic use of AdGFPFasL and small molecule inhibitors of ceramide metabolism in prostate and head and neck cancers: a status reportJ S Norris, A Bielawska, T Day, et al.
Elife|November 1, 2021
A novel, ataxic mouse model of ataxia telangiectasia caused by a clinically relevant nonsense mutationHarvey Perez, May F Abdallah, Jose I Chavira, et al.
The Journal of Experimental Medicine|March 16, 2021
ILC3s control splenic cDC homeostasis via lymphotoxin signalingMatthias Vanderkerken, Antonio P Baptista, Marco De Giovanni, et al.
Injury|August 26, 2022
Assessment of safety and effectiveness of non-neurosurgical management for minimal traumatic brain injury (TBI)Jeffrey W Chen, Aaron Yengo-Kahn, Silky Chotai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2020
Results of the ADAPT Phase 3 Study of Rocapuldencel-T in Combination with Sunitinib as First-Line Therapy in Patients with Metastatic Renal Cell CarcinomaRobert A Figlin, Nizar M Tannir, Robert G Uzzo, et al.
Frontiers in Bioscience : a Journal and Virtual Library|November 6, 2007
Acid ceramidase inhibition: a novel target for cancer therapyXiang Liu, Saeed Elojeimy, Lorianne S Turner, et al.
Expert Review of Gastroenterology & Hepatology|March 10, 2017
Effectiveness of interferon-free therapy for the treatment of HCV-patients with compensated cirrhosis treated through the Irish early access programE Gray, A O'Leary, C Bergin, et al.
Pageof 38